263 related articles for article (PubMed ID: 21120364)
21. Preclinical evaluation of combined therapy with amiodarone and low-dose benznidazole in a mouse model of chronic Trypanosoma cruzi infection.
Barbosa JMC; Pedra-Rezende Y; Mata-Santos HA; Vilar-Pereira G; Melo TG; Ramos IP; Gibaldi D; Moreira OC; Nunes DF; Batista MM; Lannes-Vieira J; Daliry A; Salomão K
Biomed Pharmacother; 2024 Jun; 175():116742. PubMed ID: 38754265
[TBL] [Abstract][Full Text] [Related]
22. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi.
Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL
Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419
[TBL] [Abstract][Full Text] [Related]
23. Unveiling benznidazole's mechanism of action through overexpression of DNA repair proteins in Trypanosoma cruzi.
Rajão MA; Furtado C; Alves CL; Passos-Silva DG; de Moura MB; Schamber-Reis BL; Kunrath-Lima M; Zuma AA; Vieira-da-Rocha JP; Garcia JB; Mendes IC; Pena SD; Macedo AM; Franco GR; de Souza-Pinto NC; de Medeiros MH; Cruz AK; Motta MC; Teixeira SM; Machado CR
Environ Mol Mutagen; 2014 May; 55(4):309-21. PubMed ID: 24347026
[TBL] [Abstract][Full Text] [Related]
24. ABCG-like transporter of Trypanosoma cruzi involved in benznidazole resistance: gene polymorphisms disclose inter-strain intragenic recombination in hybrid isolates.
Franco J; Ferreira RC; Ienne S; Zingales B
Infect Genet Evol; 2015 Apr; 31():198-208. PubMed ID: 25660041
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility and natural resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease.
Filardi LS; Brener Z
Trans R Soc Trop Med Hyg; 1987; 81(5):755-9. PubMed ID: 3130683
[TBL] [Abstract][Full Text] [Related]
26. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
Villarreal D; Barnabé C; Sereno D; Tibayrenc M
Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
[TBL] [Abstract][Full Text] [Related]
27. Trypanosoma cruzi: chemotherapy with benznidazole in mice inoculated with strains from Paraná state and from different endemic areas of Brazil.
Toledo MJ; Guilherme AL; da Silva JC; de Gasperi MV; Mendes AP; Gomes ML; de Araújo SM
Rev Inst Med Trop Sao Paulo; 1997; 39(5):283-90. PubMed ID: 9661307
[TBL] [Abstract][Full Text] [Related]
28. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
[TBL] [Abstract][Full Text] [Related]
29. Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.
Batista Dda G; Batista MM; de Oliveira GM; Britto CC; Rodrigues AC; Stephens CE; Boykin DW; Soeiro Mde N
PLoS One; 2011; 6(7):e22155. PubMed ID: 21814568
[TBL] [Abstract][Full Text] [Related]
30. In vivo selection of a population of Trypanosoma cruzi and clones resistant to benznidazole.
Murta SM; Romanha AJ
Parasitology; 1998 Feb; 116 ( Pt 2)():165-71. PubMed ID: 9509026
[TBL] [Abstract][Full Text] [Related]
31. Changes of RAPD profile of Trypanosoma cruzi II with Canova and Benznidazole.
Aleixo DL; Ferraz FN; de Melo CS; Gomes ML; Toledo MJ; Kaneshima EN; Bersani-Amado CA; Araújo SM
Homeopathy; 2008 Apr; 97(2):59-64. PubMed ID: 18439965
[TBL] [Abstract][Full Text] [Related]
32. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
[TBL] [Abstract][Full Text] [Related]
33. Response to chemotherapy with benznidazole of clones isolated from the 21SF strain of Trypanosoma cruzi (biodeme Type II, Trypanosoma cruzi II).
Campos RF; Guerreiro ML; Sobral Kde S; Lima Rde C; Andrade SG
Rev Soc Bras Med Trop; 2005; 38(2):142-6. PubMed ID: 15821788
[TBL] [Abstract][Full Text] [Related]
34. The immunomodulatory effects of the Enalapril in combination with Benznidazole during acute and chronic phases of the experimental infection with Trypanosoma cruzi.
Leite ALJ; Paula Costa G; Lopes LR; Reis Mota LWD; Vieira PMA; Talvani A
Acta Trop; 2017 Oct; 174():136-145. PubMed ID: 28720491
[TBL] [Abstract][Full Text] [Related]
35. Benznidazole therapy during acute phase of Chagas disease reduces parasite load but does not prevent chronic cardiac lesions.
Caldas IS; Talvani A; Caldas S; Carneiro CM; de Lana M; da Matta Guedes PM; Bahia MT
Parasitol Res; 2008 Jul; 103(2):413-21. PubMed ID: 18454349
[TBL] [Abstract][Full Text] [Related]
36. Complexation of the anti-Trypanosoma cruzi drug benznidazole improves solubility and efficacy.
Nogueira Silva JJ; Pavanelli WR; Gutierrez FR; Alves Lima FC; Ferreira da Silva AB; Santana Silva J; Wagner Franco D
J Med Chem; 2008 Jul; 51(14):4104-14. PubMed ID: 18570370
[TBL] [Abstract][Full Text] [Related]
37. Role of nucleic acid amplification assays in monitoring treatment response in chagas disease: Usefulness in clinical trials.
Sulleiro E; Muñoz-Calderon A; Schijman AG
Acta Trop; 2019 Nov; 199():105120. PubMed ID: 31376368
[TBL] [Abstract][Full Text] [Related]
38. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
39. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
[TBL] [Abstract][Full Text] [Related]
40. Activity of the sesquiterpene lactone goyazensolide against
Milagre MM; Branquinho RT; Gonçalves MF; de Assis G; de Oliveira MT; Reis L; Saúde-Guimarães DA; de Lana M
Parasitology; 2020 Jan; 147(1):108-119. PubMed ID: 31455451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
